Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pain block could make kidney stone treatment less painful

NCT ID NCT07177625

Symptom relief Sponsor: Elazıg Fethi Sekin Sehir Hastanesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at whether a retrolaminar block—a numbing injection near the spine—can reduce pain and improve comfort for people undergoing shock wave treatment for kidney stones. About 90 adults will be divided into three groups: one receiving the block, one receiving standard sedation, and one receiving no extra pain relief. Researchers will measure pain levels and the need for additional pain medication during and after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Retrolaminar block (a numbing injection near the spine)
What this could lead to
If it works, this could offer a safer, more effective pain relief option for people undergoing shock wave treatment for kidney stones.
What could go wrong
This is a small, early observational study, so results may not apply to everyone. The block may not reduce pain better than standard care and carries rare risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Nov 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients scheduled for ESWL for urinary system stones at Elazığ Fethi Sekin City Hospital. Participants will be assigned to receive Retrolaminar Block, standard sedoanalgesia, or no intervention. Pain intensity, vital signs, procedural parameters, and adverse events will be monitored.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * ASA Physical Status I-III * Undergoing ESWL in prone position * Provided written informed consent Exclusion Criteria: * ASA Physical Status IV or higher * Allergy to local anesthetics or sedatives * Coagulopathy or anticoagulant use * Local infection at injection site * Severe spinal deformity or anatomical abnormality preventing block * Cognitive impairment or inability to use VAS * Pregnancy * Chronic opioid use or chronic pain medication * Emergency ESWL * Previous open surgery at block site * Intraoperative hemodynamic instability or severe complications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urolithiasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

urolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urolithiasis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Elazığ Fethi Sekin City Hospital

    Elâzığ, 23100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.